Add Company
Join Now

NFlection Therapeutics Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NFlection Therapeutics's estimated annual revenue is currently $542.5k per year.(i)
  • NFlection Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • NFlection Therapeutics has 7 Employees.(i)
  • NFlection Therapeutics grew their employee count by -30% last year.

NFlection Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
Director Clinical OperationsReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is NFlection Therapeutics?

NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi. To address these rare disorders, which are also referred to as RASopathies because they are driven by the aberrant activation of the Ras/Raf/MEK/ERK pathway, we are developing first-in-class MEK (mitogen-activated protein kinase kinase) inhibitors as topical treatments.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$542.5k

Revenue (est)

-30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M7-22%N/A
#2
$0.1M70%$25M
#3
$0.5M7N/AN/A
#4
$0.5M7N/AN/A
#5
$0.1M70%$3.1M